PL2400973T3 - Identyfikacja zewnątrzkomórkowej postaci PTEN, która może być zastosowana do leczenia raka - Google Patents

Identyfikacja zewnątrzkomórkowej postaci PTEN, która może być zastosowana do leczenia raka

Info

Publication number
PL2400973T3
PL2400973T3 PL10744058T PL10744058T PL2400973T3 PL 2400973 T3 PL2400973 T3 PL 2400973T3 PL 10744058 T PL10744058 T PL 10744058T PL 10744058 T PL10744058 T PL 10744058T PL 2400973 T3 PL2400973 T3 PL 2400973T3
Authority
PL
Poland
Prior art keywords
pten
identification
treat cancer
extracellular form
extracellular
Prior art date
Application number
PL10744058T
Other languages
English (en)
Inventor
Ramon Parsons
Original Assignee
The Trustees Of Columbia University In The City Of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Trustees Of Columbia University In The City Of New York filed Critical The Trustees Of Columbia University In The City Of New York
Publication of PL2400973T3 publication Critical patent/PL2400973T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL10744058T 2009-02-17 2010-02-17 Identyfikacja zewnątrzkomórkowej postaci PTEN, która może być zastosowana do leczenia raka PL2400973T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20797409P 2009-02-17 2009-02-17

Publications (1)

Publication Number Publication Date
PL2400973T3 true PL2400973T3 (pl) 2017-09-29

Family

ID=42634379

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10744058T PL2400973T3 (pl) 2009-02-17 2010-02-17 Identyfikacja zewnątrzkomórkowej postaci PTEN, która może być zastosowana do leczenia raka

Country Status (19)

Country Link
US (1) US9017981B2 (pl)
EP (1) EP2400973B1 (pl)
JP (2) JP5767117B2 (pl)
CN (1) CN102387810B (pl)
AU (2) AU2010216370A1 (pl)
BR (1) BRPI1005951A2 (pl)
CA (1) CA2752590C (pl)
CY (1) CY1118861T1 (pl)
DK (1) DK2400973T3 (pl)
ES (1) ES2623393T3 (pl)
HR (1) HRP20170306T1 (pl)
HU (1) HUE032028T2 (pl)
LT (1) LT2400973T (pl)
MX (1) MX2011008695A (pl)
PL (1) PL2400973T3 (pl)
PT (1) PT2400973T (pl)
SI (1) SI2400973T1 (pl)
SM (1) SMT201700159T1 (pl)
WO (1) WO2010096173A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012009565A (es) * 2010-02-17 2014-02-27 Univ Columbia Uso de la secuencia lider de pten largo para la liberacion de moleculas transmembrana.
WO2015105957A1 (en) 2014-01-08 2015-07-16 Shriners Hospitals For Children Pten antagonist peptides and methods of using the same
KR102780496B1 (ko) * 2016-07-29 2025-03-11 오하이오 스테이트 이노베이션 파운데이션 종양용해성 바이러스에 의한 PTEN-Long의 발현
CN109022461B (zh) * 2017-06-08 2022-01-14 中山大学附属第一医院 一种PTEN基因的上游开放阅读框45aa-uORF核苷酸序列及其编码的多肽的应用
CN108504671A (zh) * 2018-03-28 2018-09-07 宁波市医疗中心李惠利医院 一种PTEN-Long蛋白纯化制备方法
KR102995657B1 (ko) 2018-03-29 2026-07-28 테크니온 리서치 엔드 디벨로프먼트 화운데이션 엘티디. Pten 억제제를 포함하는 소포 및 이의 용도
US20220169997A1 (en) * 2019-04-12 2022-06-02 Therapten Biosciences Inc. Compositions and methods to manufacture tumor suppressor fusions
KR20220038485A (ko) * 2019-08-05 2022-03-28 메조블라스트 인터내셔널 에스에이알엘 바이러스 벡터를 포함하는 세포 조성물 및 치료 방법
CN112813046A (zh) * 2021-01-08 2021-05-18 北京大学 一种pten亚型蛋白及其应用
CN112877309B (zh) * 2021-02-19 2022-05-17 北京大学 一种N端延长型PTEN亚型PTENζ蛋白及其编码基因和应用
WO2024163335A2 (en) * 2023-01-30 2024-08-08 The Board Of Regents Of The University Of Texas System Pten gene therapy vectors and uses thereof
CN121401191A (zh) * 2025-12-12 2026-01-27 山东大学齐鲁医院 一种通过重塑残存神经环路介导脊髓损伤修复的核酸凝胶及其构建方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482795B1 (en) * 1997-01-30 2002-11-19 Myriad Genetics, Inc. Tumor suppressor designated TS10q23.3
AU2001265137B2 (en) * 2000-05-30 2007-06-14 Indiana University Research And Technology Corporation Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
US20040266713A1 (en) 2003-04-23 2004-12-30 Shan Lu Methods and compositions for solid tumor treatment
WO2006034455A2 (en) 2004-09-23 2006-03-30 Vasgene Therapeutics, Inc. Polipeptide compounds for inhibiting angiogenesis and tumor growth
MX2012009565A (es) 2010-02-17 2014-02-27 Univ Columbia Uso de la secuencia lider de pten largo para la liberacion de moleculas transmembrana.

Also Published As

Publication number Publication date
HRP20170306T1 (hr) 2017-04-21
DK2400973T3 (en) 2017-03-06
MX2011008695A (es) 2011-10-14
JP2015231372A (ja) 2015-12-24
JP5973035B2 (ja) 2016-08-17
SMT201700159T1 (it) 2017-05-08
EP2400973A2 (en) 2012-01-04
EP2400973B1 (en) 2016-11-30
CN102387810B (zh) 2017-08-04
AU2010216370A1 (en) 2011-09-22
HUE032028T2 (en) 2017-08-28
LT2400973T (lt) 2017-04-10
CA2752590C (en) 2017-08-22
SI2400973T1 (sl) 2017-05-31
CN102387810A (zh) 2012-03-21
WO2010096173A3 (en) 2010-10-21
JP5767117B2 (ja) 2015-08-19
BRPI1005951A2 (pt) 2016-10-11
US20120039861A1 (en) 2012-02-16
EP2400973A4 (en) 2013-02-27
ES2623393T3 (es) 2017-07-11
CA2752590A1 (en) 2010-08-26
WO2010096173A2 (en) 2010-08-26
CY1118861T1 (el) 2018-01-10
US9017981B2 (en) 2015-04-28
AU2016231517A1 (en) 2016-10-06
PT2400973T (pt) 2017-03-07
JP2012517827A (ja) 2012-08-09
AU2016231517B2 (en) 2018-01-25

Similar Documents

Publication Publication Date Title
IL289300A (en) Combination therapy for treating cancer
CL2015001157A1 (es) Composiciones y métodos para tratar proteinopatías.
BR112012005594A2 (pt) tratamento de câncer
IL239007B (en) Eribulin for use in the treatment of breast cancer
SMT201600050B (it) Mezzi e metodi per trattare il dlbcl
LT2707030T (lt) Vėžio gydymas
PL2544682T3 (pl) Fitokannabinoidy w leczeniu glejaka
PT2897620T (pt) Método de tratamento de cancro
HUE047198T2 (hu) Fitokannabinoidok emlõrák kezelésére
HUE046667T2 (hu) Rák kombinatív kezelése
IL224370B (en) Combination treatment for prostate carcinoma
BR112014012880A2 (pt) tratamento imunogênico do câncer
DK2646208T3 (da) Miljøvenlig træbehandlingsprocess
PL2630108T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
PL2739153T3 (pl) Leczenie raka sutka
SI2400973T1 (sl) Identifikacija ekstracelularne oblike PTEN, ki se lahko uporablja za zdravljenje tumorjev
BR112012002797A2 (pt) tratamento de câncer de próstata
FR2955040B1 (fr) Pre-broyeur ou pre-dechiqueteur
BR112013011659A2 (pt) métodos de tratamento do câncer
IL230134B (en) Catheter connector
HRP20170225T1 (hr) Fosfoplatini i njihova uporaba za liječenje karcinoma
ES1072644Y (es) Botiquin inteligente
PL2742356T3 (pl) Środki prognostyczne w leczeniu nowotworów
SI2892925T1 (sl) Kombinacijsko zdravljenje raka
FI20106078A0 (fi) Puukuitupitoisen jakeen käsittely